These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9527459)

  • 1. [Limiting prescribing freedom in the hospital].
    Jansen C
    Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):635-7; discussion 638. PubMed ID: 9527459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Limited prescribing freedom by federal cost regulation?].
    Lasek R
    Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):633-5. PubMed ID: 9527458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacists want to assume penalty].
    MMW Fortschr Med; 2006 May; 148(20):55. PubMed ID: 16805194
    [No Abstract]   [Full Text] [Related]  

  • 4. [Incentives for especially cost effective prescribing. The physician protects his budget, the patient saves co-pay].
    Schmidt K
    MMW Fortschr Med; 2006 Nov; 148(44):57, 59. PubMed ID: 17619443
    [No Abstract]   [Full Text] [Related]  

  • 5. [Family physicians resist high prescription risk].
    Schmidt K
    MMW Fortschr Med; 2003 May; 145(20):58. PubMed ID: 12822233
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bonus in reduced prescription costs. Would you comply?].
    Schmidt K
    MMW Fortschr Med; 2002 Sep; 144(39):45-6. PubMed ID: 12422688
    [No Abstract]   [Full Text] [Related]  

  • 7. [GMG proposal for non-prescription medications. Expensive cost savings].
    MMW Fortschr Med; 2004 Aug; 146(31-32):48. PubMed ID: 15529713
    [No Abstract]   [Full Text] [Related]  

  • 8. [Barmer reimbursement insurance pays pharmacists a fee for monitoring physicians. Pharmacists now control their prescriptions!].
    Schmidt K
    MMW Fortschr Med; 2004 May; 146(21):55-6. PubMed ID: 15373087
    [No Abstract]   [Full Text] [Related]  

  • 9. [Nine months German Statutory Health Insurance Structural Reform Law--effects and perspectives].
    Engel H
    Gesundheitswesen; 1994 Feb; 56(2):76-9. PubMed ID: 8148595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Future impact of the legal health provision contract for hospitals according to BPfIV, KHG and SGB V].
    Bauer H
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():659-62. PubMed ID: 9101963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug costs should be lower. Hessian colleagues beaten without compassion].
    MMW Fortschr Med; 2004 Jul; 146(27-28):49. PubMed ID: 15526667
    [No Abstract]   [Full Text] [Related]  

  • 12. [New cost saving legislation for drugs. National health insurance carriers do not want to believe Ulla Schmidt}].
    MMW Fortschr Med; 2006 Feb; 148(5):45. PubMed ID: 16518939
    [No Abstract]   [Full Text] [Related]  

  • 13. [DRG in the context of current health policy].
    Lauterbach KW; Lüngen M
    Med Klin (Munich); 2003 Aug; 98(8):467-71. PubMed ID: 13678038
    [No Abstract]   [Full Text] [Related]  

  • 14. [New drugs must henceforth be better than the current standard. What remains for physician therapy autonomy?].
    Schmidt K
    MMW Fortschr Med; 2006 Dec; 148(49-50):61, 63. PubMed ID: 17619334
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug prescribing in primary health care for diabetic and non-diabetic patients: effect of therapeutic drug budgeting].
    Jünger C; Rathmann W; Giani G
    Gesundheitswesen; 1999 Dec; 61(12):607-13. PubMed ID: 10666939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Can physicians really save still more in drug prescriptions?].
    Schmidt K
    MMW Fortschr Med; 2006 Feb; 148(5):44-5. PubMed ID: 16518938
    [No Abstract]   [Full Text] [Related]  

  • 17. [Preventing prescription drug penalty. Advantages of cost savings].
    MMW Fortschr Med; 2009 Jul; 151(30-33):81. PubMed ID: 19722474
    [No Abstract]   [Full Text] [Related]  

  • 18. [The new federal patient insurance regulation--initial experiences with implementation and preparation for 1996].
    Düllings J
    Gesundheitswesen; 1995 Jun; 57(6):322-5. PubMed ID: 7663070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prerequisites in prescribing practice: physician decision processes].
    Dierks C
    Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):620-4. PubMed ID: 9527454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Legal dispute about the black drug list. Irrespective of positive or negative list--I am in favor].
    Thöns M
    MMW Fortschr Med; 2006 Oct; 148(40):8. PubMed ID: 17338085
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.